Annual Long Term Debt
$10.01 M
+$7.39 M+282.16%
December 31, 2023
Summary
- As of February 8, 2025, KNSA annual long term debt is $10.01 million, with the most recent change of +$7.39 million (+282.16%) on December 31, 2023.
- During the last 3 years, KNSA annual long term debt has risen by +$5.13 million (+105.10%).
- KNSA annual long term debt is now at all-time high.
Performance
KNSA Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$8.56 M
-$753.00 K-8.08%
September 30, 2024
Summary
- As of February 8, 2025, KNSA quarterly long term debt is $8.56 million, with the most recent change of -$753.00 thousand (-8.08%) on September 30, 2024.
- Over the past year, KNSA quarterly long term debt has dropped by -$2.09 million (-19.59%).
- KNSA quarterly long term debt is now -24.10% below its all-time high of $11.28 million, reached on June 30, 2023.
Performance
KNSA Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
KNSA Long Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +282.2% | -19.6% |
3 y3 years | +105.1% | +144.8% |
5 y5 years | +100.0% | +515.7% |
KNSA Long Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +282.2% | -24.1% | +570.1% |
5 y | 5-year | at high | +947.6% | -24.1% | >+9999.0% |
alltime | all time | at high | -100.0% | -24.1% | -100.0% |
Kiniksa Pharmaceuticals Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $8.56 M(-8.1%) |
Jun 2024 | - | $9.32 M(-5.5%) |
Mar 2024 | - | $9.86 M(-1.4%) |
Dec 2023 | $10.01 M(+282.2%) | $10.01 M(-6.1%) |
Sep 2023 | - | $10.65 M(-5.6%) |
Jun 2023 | - | $11.28 M(+429.0%) |
Mar 2023 | - | $2.13 M(-18.5%) |
Dec 2022 | $2.62 M(-1.9%) | $2.62 M(-23.8%) |
Sep 2022 | - | $3.44 M(+168.8%) |
Jun 2022 | - | $1.28 M(-39.0%) |
Mar 2022 | - | $2.10 M(-21.5%) |
Dec 2021 | $2.67 M | $2.67 M(-23.7%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | $3.50 M(-0.0%) |
Jun 2021 | - | $3.50 M(-16.7%) |
Mar 2021 | - | $4.20 M(-13.9%) |
Dec 2020 | $4.88 M(+410.8%) | $4.88 M(+8769.1%) |
Sep 2020 | - | $55.00 K(-60.4%) |
Jun 2020 | - | $139.00 K(-74.8%) |
Mar 2020 | - | $551.00 K(-42.3%) |
Dec 2019 | $955.00 K(>+9900.0%) | $955.00 K(-31.3%) |
Sep 2019 | - | $1.39 M(-23.5%) |
Jun 2019 | - | $1.82 M(-18.8%) |
Mar 2019 | - | $2.24 M(>+9900.0%) |
Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Kiniksa Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual long term debt year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly long term debt year-on-year change?
What is Kiniksa Pharmaceuticals annual long term debt?
The current annual long term debt of KNSA is $10.01 M
What is the all time high annual long term debt for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual long term debt is $10.01 M
What is Kiniksa Pharmaceuticals annual long term debt year-on-year change?
Over the past year, KNSA annual long term debt has changed by +$7.39 M (+282.16%)
What is Kiniksa Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of KNSA is $8.56 M
What is the all time high quarterly long term debt for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly long term debt is $11.28 M
What is Kiniksa Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, KNSA quarterly long term debt has changed by -$2.09 M (-19.59%)